The American Medical Association (AMA) House of Delegates met in June to establish policy positions on topics of importance to patients and healthcare providers. The Society attends the AMA meetings to further our policy agenda by garnering the support of the House of Delegates on issues of importance to our members. This enables us to...
On May 8, the Senate Special Committee on Aging held a hearing to discuss the skyrocketing cost of insulin, which has tripled in the past 15 years, and how to reduce costs through federal policy changes. In her opening statement, Senator Susan Collins (R-ME), who is also co-chair of the Senate Diabetes Caucus, stated that:...
For any Endocrine Society members who want to learn how to advocate on behalf of endocrine science and research, you will get your chance at ENDO 2018 in Chicago! This year will see the debut of a few new sessions hosted by the Society’s Advocacy and Public Outreach Core Committee (APOCC) and the Government and...
To find out how you can become involved in the Society’s advocacy efforts, including our efforts to increase funding for the National Institutes of Health, please join us at ENDO 2018 for a special session hosted by the Advocacy and Public Outreach Core Committee (APOCC). The purpose of the session is to discuss the Society’s...
When the Rally for Medical Research took place in Washington, D.C., in September, among the voices were several Endocrine Society members. We spoke to Lindsey Trevino, PhD, T. Rajendra Kumar, PhD, Heather Patisaul, PhD, and Benson Akingbemi, PhD, about why they feel so strongly about becoming “endocrine advocates.” In September, the Endocrine Society was a... Tax reform legislation (H.R. 1) approved by the U.S. House of Representatives will increase tax liability for thousands of graduate students who serve as teaching or research assistants. Under the House-passed legislation, tuition waivers granted to graduate students would be considered taxable income. More than half (55%) of all master’s and PhD candidates who serve...
Endocrine Society Explores Policy Solutions to Address Rising Insulin Costs
Given the dramatic increases in the cost of insulin over the past decade, the Endocrine Society has been focusing on ways to address patient access to this lifesaving therapy for patients with diabetes. Our members continue to express great concern about the impact that rising insulin costs have on their patients’ diabetes treatment, as well...
Endocrine Society’s Diabetes Briefing on Capitol Hill “Goes to the Dogs”
On September 14, the Endocrine Society hosted a briefing on Capitol Hill titled “Diabetes in America: Research Accomplishments and Clinical Challenges,” sponsored by Rep. Buddy Carter (R-GA). The briefing featured presentations from Judith Fradkin, MD, of the National Institutes of Health, who shared accomplishments in diabetes research; Shivani Agarwal, MD, MPH, of the University of...
